Automated evaluation and correction of generation bias in immune receptor repert...
Automated evaluation and correction of generation bias in immune receptor repertoires
Personalized medicine is promising to change the health and prophylactics sectors, already showing large societal and economic impact. High throughput immune sequencing technologies give us insight into a unique personal medical r...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MTM2015-68140-R
METODOS ESTADISTICOS, ALGORITMOS EFICIENTES Y HERRAMIENTAS B...
Cerrado
iReceptor Plus
ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T CELL...
9M€
Cerrado
nextDART
Next generation Detection of Antigen Responsive T cells
1M€
Cerrado
Cellularity
The critical shift to single-cell formats in functional anal...
5M€
Cerrado
SAF2017-90781-REDI
FOMENTO DEL USO DE LAS TECNOLOGIAS OMICAS EN MEDICINA PERSON...
79K€
Cerrado
STRUGGLE
Statistical physics of immune viral co evolution
2M€
Cerrado
Información proyecto PGEN
Duración del proyecto: 27 meses
Fecha Inicio: 2018-08-24
Fecha Fin: 2020-11-30
Descripción del proyecto
Personalized medicine is promising to change the health and prophylactics sectors, already showing large societal and economic impact. High throughput immune sequencing technologies give us insight into a unique personal medical record - our immune system’s memory of all encountered infections and the successful solutions our body found. Unfortunately, reading this record requires advanced statistical tools making it often inaccessible to biologists and medical practitioners. PGEN offers a solution that will fill this gap between modern technology and applications by developing commercialisation solutions for an immune repertoire analysis software. PGEN builds on the methodologies developed during the ERC Starting Grant RECOGNIZE to provide a user-friendly versatile software prototype that will give researchers in the life scientists and medical practitioners without bioinformatic training an overview of the statistical properties of the immune repertoires they are studying. PGEN will explore the impact on medicine and biotechnology of this software platform that identifies non-standard immune responses that can be exploited in vaccine design and novel personalised therapies. Currently no software exists that a medical practitioner can use to characterize the baseline immune repertoire of a healthy person. Knowing this baseline is essential for identifying immune system disfunction and applying immune repertoire sequencing technologies in biotechnology and medicine. The PGEN software platform will provide doctors and biologists with a statistical tool that will help them make informed decisions about treatment, prophylactics and future research. PGEN will pursue commercialization and market solutions both within academia, the biotechnology and medical sectors.